Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Cresemba“
Suchtreffer
Begriffe & Kennungen
Cresemba · 4.5 · (CYP3A4/5 induction) Rifabutin Not studied. The concomitant administration (strong CYP3A4/5 inducer) Isavucona
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Rifabutin Not studied. The concomitant administration (strong CYP3A4/5 inducer) Isavucona
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 inhibition) Antifungals Ketoconazole Isavuconazole: The concomitant administration (strong CYP3A4/5
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 inhibition) Herbal medicines St John’s wort Not studied. The concomitant administration (strong CYP3
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 inhibition) Herbal medicines St John’s wort Not studied. The concomitant administration (strong CYP3
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 inhibition) Other NNRTI (e.g. nevirapine) Not studied. No isavuconazole dose (CYP3A4/5 and 2B6 induc
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 inhibition) Other NNRTI (e.g. nevirapine) Not studied. No isavuconazole dose (CYP3A4/5 and 2B6 induc
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 inhibition) Other protease inhibitors (e.g. Not studied. No isavuconazole dose fosamprenavir) Protea
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 inhibition) Other protease inhibitors (e.g. Not studied. No isavuconazole dose fosamprenavir) Protea
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 inhibition) Ritonavir (at doses >200 mg Not studied. The concomitant administration every 12 hours)
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 inhibition) Ritonavir (at doses >200 mg Not studied. The concomitant administration every 12 hours)
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 inhibition) Saquinavir Not studied. No isavuconazole dose (strong CYP3A4 inhibitor) Saquinavir conce
Eintrag öffnenCresemba · 4.5 · (Mechanism unknown) Other anticancer agents Not studied. No isavuconazole dose (daunorubicin, doxorubicin, Dau
Eintrag öffnenCresemba · 4.5 · (Mechanism unknown) Other anticancer agents Not studied. No isavuconazole dose (daunorubicin, doxorubicin, Dau
Eintrag öffnenCresemba · 4.5 · (UGT inhibition) Prednisone Prednisolone (active metabolite): Co-administration should be (CYP3A4 substrate) A
Eintrag öffnenCresemba · 4.5 · (UGT inhibition) Prednisone Prednisolone (active metabolite): Co-administration should be (CYP3A4 substrate) A
Eintrag öffnenCresemba · 4.5 · 11 Digoxin Digoxin: No isavuconazole dose (P-gp substrate) AUCinf: ↑ 25% adjustment necessary. Cmax: ↑ 33% Dig
Eintrag öffnenCresemba · 4.5 · 28 Medicinal products that induce CYP3A4/5
Eintrag öffnenCresemba · 4.5 · 29 Interactions between isavuconazole and co-administered medicinal products are listed in Table 3 (increase i
Eintrag öffnenCresemba · 4.5 · 32 ritonavir 100 mg every 12 hours (Mechanism unknown) required, but careful monitoring for any occurrence of
Eintrag öffnen